Cargando…

Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679801/ https://www.ncbi.nlm.nih.gov/pubmed/37966846 http://dx.doi.org/10.1182/bloodadvances.2023011828

Ejemplares similares

Huynh A, Arnold DM, Michael JV, et al. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023;7(2):246-250.
Publicado: (2023)

Ilich A, Gernsheimer TB, Triulzi DJ, et al. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia. Blood Adv. 2023;7(6):900-908.
Publicado: (2023)

Mazzara S, Travaini L, Botta F, et al. Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL. Blood Adv. 2023;7(4):630-643.
Publicado: (2023)

Hertz L, Flormann D, Birnbaumer L, et al. Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood Adv. 2023;7(6):1033-1039.
Publicado: (2023)

DuMontier C, La J, Bihn J, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275-6284.
Publicado: (2023)

Alquezar-Artieda N, Kuzilkova D, Roberts J, et al. Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy. Blood Adv. 2023;7(10):2228-2236.
Publicado: (2023)

Behrens' General Botany
Publicado: (1885)

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients
por: Schuelke, Matthew R., et al.
Publicado: (2023)

Identification of the replication region in pBCNF5603, a bacteriocin-encoding plasmid, in the enterotoxigenic Clostridium perfringens strain F5603
por: Miyamoto, Kazuaki, et al.
Publicado: (2015)

Efficacy and safety of emapalumab in macrophage activation syndrome
por: De Benedetti, Fabrizio, et al.
Publicado: (2023)

Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)
por: Merli, Pietro, et al.
Publicado: (2020)

Successful use of emapalumab in refractory hemophagocytic lymphohistiocytosis in a child with Chédiak–Higashi syndrome: a case report
por: AlAhmari, Ali, et al.
Publicado: (2023)

A multiple-testing approach to the multivariate Behrens-Fisher problem: with simulations and examples in SAS®
por: Desai, Tejas
Publicado: (2013)

Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection
por: Tucci, Francesca, et al.
Publicado: (2020)

Erratum in: IMI 2023 Digest
Publicado: (2023)

FREE AMINO ACIDS AND NUCLEIC ACID CONTENT OF CELL NUCLEI ISOLATED BY A MODIFICATION OF BEHRENS' TECHNIQUE
por: Dounce, Alexander L., et al.
Publicado: (1950)

The impact of the c.5603A>T hypomorphic variant on founder mutation screening of ABCA4 for Stargardt disease in South Africa
por: Midgley, Nicole, et al.
Publicado: (2020)

Erratum for Euro Surveill. 2023;28(1)
Publicado: (2023)

Erratum for Euro Surveill. 2023;28(22)
Publicado: (2023)

Erratum for Euro Surveill. 2023;28(15)
Publicado: (2023)

Erratum for Euro Surveill. 2023;28(27)
Publicado: (2023)

Erratum for Euro Surveill. 2023;28(27)
Publicado: (2023)

Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors
por: Cure, Erkan, et al.
Publicado: (2021)

This article corrects: “Correlation of the NBME Advanced Clinical Examination in EM and the National EM M4 exams”
por: Hiller, Katherine, et al.
Publicado: (2015)

Erratum: Alzheimer's disease drug development pipeline: 2023
Publicado: (2023)

Erratum, Vol. 20, April 13, 2023 Release
Publicado: (2023)

Smith CC, Levis MJ, Perl AE, et al. Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood Adv. 2022;6(7):2144-2155.
Publicado: (2022)

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Chellapandian, Deepak, et al.
Publicado: (2023)

Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model‐based approach
por: Jacqmin, Philippe, et al.
Publicado: (2021)

Erratum in: Editorial: International Myopia Institute White Paper Series 2023
Publicado: (2023)

The NO Answer for Autism Spectrum Disorder (Adv. Sci. 22/2023)
por: Tripathi, Manish Kumar, et al.
Publicado: (2023)

STUDIES OF TWO TYPES OF ALKALINE PHOSPHATASE IN NUCLEI ISOLATED FROM THE LIVERS OF FED AND FASTED RATS BY A MODIFICATION OF THE BEHRENS TECHNIQUE
por: Emery, Arthur J., et al.
Publicado: (1955)

Printing Three‐Dimensional Refractory Metal Patterns in Ambient Air: Toward High Temperature Sensors (Adv. Sci. 31/2023)
por: Yu, Jichuan, et al.
Publicado: (2023)

Inflammation‐Controlled Anti‐Inflammatory Hydrogels (Adv. Sci. 7/2023)
por: Helmecke, Tina, et al.
Publicado: (2023)

Superconductivity at Interfaces in Cuprate‐Manganite Superlattices (Adv. Sci. 21/2023)
por: Bonmassar, Nicolas, et al.
Publicado: (2023)

Encoding and Storage of Information in Mechanical Metamaterials (Adv. Sci. 20/2023)
por: Meng, Zhiqiang, et al.
Publicado: (2023)

Optically Programmable Living Microrouter in Vivo (Adv. Sci. 32/2023)
por: Liu, Xiaoshuai, et al.
Publicado: (2023)

Park EJ, Prajuabjinda O, Soe ZY, et al. Exosomal regulation of lymphocyte homing to the gut. Blood Adv. 2019;3(1):1-11.
Publicado: (2019)

Park EJ, Prajuabjinda O, Soe ZY, et al. Exosomal regulation of lymphocyte homing to the gut. Blood Adv. 2019;3(1):1-11.
Publicado: (2019)

Erratum to: Motion correction in simultaneous PET/MR brain imaging using sparsely sampled MR navigators: a clinically feasible tool
por: Keller, Sune H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t5drbfenla30mh6e8fr33pbh98